SAN DIEGO, Oct. 16 /PRNewswire-FirstCall/ -- Protein Polymer Technologies,
Inc. (OTC Bulletin Board: PPTI), today announced that Company President and
CEO, J. Thomas Parmeter, will present at the Rodman & Renshaw Techvest
Healthcare Conference on Wednesday, October 22, 2003, at 4:00 p.m. ET. The
investor conference is being held at The Boston Marriott Long Warf Hotel from
October 21-23, 2003.
About Protein Polymer Technologies
Protein Polymer Technologies, Inc., is a San Diego-based company focused
on developing bioactive devices to improve medical and surgical outcomes.
From its inception in 1988, PPTI has been a pioneer in protein design and
synthesis, creating an extensive portfolio of proprietary biomaterials for use
in the development of bioactive devices. These genetically engineered
biomaterials are high molecular weight proteins, processed into products with
physical and biological characteristics tailored to specific clinical
performance requirements. Targeted products include urethral bulking agents
for the treatment of stress urinary incontinence, dermal augmentation products
for cosmetic and reconstructive surgery, surgical adhesives and sealants,
scaffolds for wound healing and tissue engineering, and depots for local drug
delivery. To date, PPTI has been issued twenty-five U.S. Patents on its core
technology with corresponding issued and pending patents in key international
markets.
Safe Harbor
This press release contains forward-looking statements that are based on
management's views and expectations. Actual results could differ materially
from those expressed here; further, the Company is not obligated to comment
specifically on those differences. Risks associated with the Company's
activities include raising adequate capital to continue operations, scientific
and product development uncertainties, competitive products and approaches,
continuing collaborative partnership interest and funding, regulatory testing
and approvals, and manufacturing scale up. The reader is encouraged to refer
to the Company's 2002 Annual Report Form 10-KSB, and other recent filings with
the Securities and Exchange Commission, copies of which are available from the
Company, to further ascertain the risks associated with the above statements.
SOURCE Protein Polymer Technologies, Inc.
 back to top
CONTACT:
J. Thomas Parmeter, Ph.D., President, Chief
Executive Officer, Protein Polymer Technologies, Inc.,
+1-858-558-6064; or Jill Meleski, Assistant Vice President, The
Ruth Group, +1-646-536-7032, for Protein Polymer Technologies,
Inc.
|
